ReP USP - Resultado da busca

Artigo de periodico
Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system (2018)
Bahia, Luciana R.; Santos, Raul D.; Araujo, Denizar V.; Rosa, Roger S.; Bahia, Luciana R.
Source: Archives of endocrinology metabolism. Unidade: FM
Subjects: PACIENTES INTERNADOS, CUSTOS DOS CUIDADOS DE SAÚDE, DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAHIA, Luciana R.; SANTOS, Raul D.; ARAUJO, Denizar V.; ROSA, Roger S.; BAHIA, Luciana R. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, Rio De Janeiro, Rj, v. 62, n. 3, p. 303-308, 2018. Disponível em: < http://dx.doi.org/10.20945/2359-3997000000030 > DOI: 10.20945/2359-3997000000030.
APA
Bahia, L. R., Santos, R. D., Araujo, D. V., Rosa, R. S., & Bahia, L. R. (2018). Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, 62( 3), 303-308. doi:10.20945/2359-3997000000030
NLM
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.Available from: http://dx.doi.org/10.20945/2359-3997000000030
Vancouver
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.Available from: http://dx.doi.org/10.20945/2359-3997000000030
Artigo de periodico
Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit (2018)
Cesena, Fernando H. Y.; Santos, Raul D.
Source: American journal of cardiology. Unidade: HU
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, FÁRMACOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H. Y.; SANTOS, Raul D. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, Amsterdam, Elsevier, v. 121, n. 11, p. 1315-1320, 2018. Disponível em: < http://dx.doi.org/10.1016/j.amjcard.2018.02.011 > DOI: 10.1016/j.amjcard.2018.02.011.
APA
Cesena, F. H. Y., & Santos, R. D. (2018). Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, 121( 11), 1315-1320. doi:10.1016/j.amjcard.2018.02.011
NLM
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.Available from: http://dx.doi.org/10.1016/j.amjcard.2018.02.011
Vancouver
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.Available from: http://dx.doi.org/10.1016/j.amjcard.2018.02.011
Artigo de periodico
Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
Sturm, Amy C.; Santos, Raul D.
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, COLESTEROL, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STURM, Amy C.; SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, New York, v. 72, n. 6, p. 662-680, 2018. Disponível em: < http://dx.doi.org/10.1016/j.jacc.2018.05.044 > DOI: 10.1016/j.jacc.2018.05.044.
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.Available from: http://dx.doi.org/10.1016/j.jacc.2018.05.044
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.Available from: http://dx.doi.org/10.1016/j.jacc.2018.05.044
Artigo de periodico
Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia (2018)
Silva, Pamela Rodrigues de Souza; Krieger, Jose E.; Santos, Raul D.; Jannes, Cinthia Elim; Oliveira, Theo G. M.; Gomez, Luz Marina Gome; Pereira, Alexandre Costa
Source: Arquivos Brasileiros de Cardiologia. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, GENÉTICA, COLESTEROL, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Pamela Rodrigues de Souza; KRIEGER, Jose E.; SANTOS, Raul D.; et al. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Arquivos Brasileiros de Cardiologia, Rio De Janeiro, v. 111, n. 4, p. 578-583, 2018. Disponível em: < http://dx.doi.org/10.5935/abc.20180156 > DOI: 10.5935/abc.20180156.
APA
Silva, P. R. de S., Krieger, J. E., Santos, R. D., Jannes, C. E., Oliveira, T. G. M., Gomez, L. M. G., & Pereira, A. C. (2018). Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Arquivos Brasileiros de Cardiologia, 111( 4), 578-583. doi:10.5935/abc.20180156
NLM
Silva PR de S, Krieger JE, Santos RD, Jannes CE, Oliveira TGM, Gomez LMG, Pereira AC. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia [Internet]. Arquivos Brasileiros de Cardiologia. 2018 ; 111( 4): 578-583.Available from: http://dx.doi.org/10.5935/abc.20180156
Vancouver
Silva PR de S, Krieger JE, Santos RD, Jannes CE, Oliveira TGM, Gomez LMG, Pereira AC. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia [Internet]. Arquivos Brasileiros de Cardiologia. 2018 ; 111( 4): 578-583.Available from: http://dx.doi.org/10.5935/abc.20180156
Artigo de periodico
Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf (2018)
Al-rasadi, Khalid; Santos, Raul D.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: ARÁBIA, HIPERCOLESTEROLEMIA, DIABETES MELLITUS, PROGNÓSTICO, SÍNDROME CORONARIANA AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AL-RASADI, Khalid; SANTOS, Raul D. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. Journal of clinical lipidology, New York, v. 12, n. 3, p. 685-692, 2018. Disponível em: < http://dx.doi.org/10.1016/j.jacl.2018.02.003 > DOI: 10.1016/j.jacl.2018.02.003.
APA
Al-rasadi, K., & Santos, R. D. (2018). Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf. Journal of clinical lipidology, 12( 3), 685-692. doi:10.1016/j.jacl.2018.02.003
NLM
Al-rasadi K, Santos RD. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf [Internet]. Journal of clinical lipidology. 2018 ; 12( 3): 685-692.Available from: http://dx.doi.org/10.1016/j.jacl.2018.02.003
Vancouver
Al-rasadi K, Santos RD. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf [Internet]. Journal of clinical lipidology. 2018 ; 12( 3): 685-692.Available from: http://dx.doi.org/10.1016/j.jacl.2018.02.003
Artigo de periodico
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) (2018)
Danchin, Nicolas; Santos, Raul D.
Source: European journal of preventive cardiology. Unidade: FM
Subjects: ESTATINAS, DOENÇAS CARDIOVASCULARES, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANCHIN, Nicolas; SANTOS, Raul D. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, London, v. 25, n. 10, p. 1087-1094, 2018. Disponível em: < http://dx.doi.org/10.1177/2047487318777079 > DOI: 10.1177/2047487318777079.
APA
Danchin, N., & Santos, R. D. (2018). Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, 25( 10), 1087-1094. doi:10.1177/2047487318777079
NLM
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.Available from: http://dx.doi.org/10.1177/2047487318777079
Vancouver
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.Available from: http://dx.doi.org/10.1177/2047487318777079
Artigo de periodico
PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia (2017)
Ito, Matthew K.; Santos, Raul D.
Source: The Journal of Clinical Pharmacology. Unidade: FM
Subjects: LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA, DOENÇAS GENÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ITO, Matthew K.; SANTOS, Raul D. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, Stamford, v. 57, n. 1, p. 7-32, 2017. Disponível em: < http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf > DOI: 10.1002/jcph.766.
APA
Ito, M. K., & Santos, R. D. (2017). PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, 57( 1), 7-32. doi:10.1002/jcph.766
NLM
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Vancouver
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Artigo de periodico
Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries (2017)
Santos, Raul D.; Bourbon, Mafalda; Alonso, Rodrigo; Cuevas, Ada; Vasques-Cardenas, Norma Alexandra; Pereira, Alexandre C.; Merchan, Alonso; Alves, Ana Catarina; Medeiros, Ana Margarida; Jannes, Cinthia E.; Krieger, Jose E.; Schreier, Laura; Isla, Leopoldo Perez de; Magana-Torres, Maria Teresa; Stoll, Mario; Mata, Nelva; Dell Oca, Nicolas; Corral, Pablo; Asenjo, Sylvia; Banares, Virginia G.; Reyes, Ximena; Mata, Pedro
Source: Journal of clinical lipidology. Unidade: FM
Subjects: RASTREAMENTO, COLESTEROL, HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D.; BOURBON, Mafalda; ALONSO, Rodrigo; et al. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. Journal of clinical lipidology, New York, n. 1, p. 160-166, 2017. Disponível em: < http://dx.doi.org/10.1016/j.jacl.2016.11.004 > DOI: 10.1016/j.jacl.2016.11.004.
APA
Santos, R. D., Bourbon, M., Alonso, R., Cuevas, A., Vasques-Cardenas, N. A., Pereira, A. C., et al. (2017). Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. Journal of clinical lipidology, ( 1), 160-166. doi:10.1016/j.jacl.2016.11.004
NLM
Santos RD, Bourbon M, Alonso R, Cuevas A, Vasques-Cardenas NA, Pereira AC, Merchan A, Alves AC, Medeiros AM, Jannes CE, Krieger JE, Schreier L, Isla LP de, Magana-Torres MT, Stoll M, Mata N, Dell Oca N, Corral P, Asenjo S, Banares VG, Reyes X, Mata P. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries [Internet]. Journal of clinical lipidology. 2017 ;( 1): 160-166.Available from: http://dx.doi.org/10.1016/j.jacl.2016.11.004
Vancouver
Santos RD, Bourbon M, Alonso R, Cuevas A, Vasques-Cardenas NA, Pereira AC, Merchan A, Alves AC, Medeiros AM, Jannes CE, Krieger JE, Schreier L, Isla LP de, Magana-Torres MT, Stoll M, Mata N, Dell Oca N, Corral P, Asenjo S, Banares VG, Reyes X, Mata P. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries [Internet]. Journal of clinical lipidology. 2017 ;( 1): 160-166.Available from: http://dx.doi.org/10.1016/j.jacl.2016.11.004
Artigo de periodico
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (2017)
Ridker, Paul M.; Revkin, James; Amarenco, Pierre; Brunell, Robert; Curto, Madelyn; Civeira, Fernando; Flather, Marcus; Glynn, Robert J.; Gregoire, Jean; Jukema, J. Wouter; Karpov, Yuri; Kastelein, John J.P.; Koenig, Wolfgang; Lorenzatti, Alberto; Manga, Pravin; Masiukiewicz, Urszula; Miller, Michael; Mosterd, Arend; Murin, Jan; Nicolau, Jose C.; Nissen, Steven; Ponikowski, Piotr; Santos, Raul D.; Schwartz, Pamela F.; Soran, Handrean; White, Harvey; Wright, R. Scott; Vrablik, Michal; Yunis, Carla; Shear, Charles L.; Tardif, Jean-Claude
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, PLACEBO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M.; REVKIN, James; AMARENCO, Pierre; et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, Boston, v. 376, n. 16, p. 1527-1539, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488 > DOI: 10.1056/NEJMoa1701488.
APA
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376( 16), 1527-1539. doi:10.1056/NEJMoa1701488
NLM
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Vancouver
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Artigo de periodico
Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 (2017)
Lotufo, Paulo A.; Santos, Raul D.; Sposito, Andrei C.; Bertolami, Marcelo; Rocha-Faria Neto, Jose; Izar, M. Cristina; Szwarcwald, Celia; Prado, Rogério R.; Stoppa, Sheila R.; Malta, Deborah C.; Bensenor, Isabela M.
Source: Arquivos Brasileiros de Cardiologia. Unidade: FM
Subjects: COLESTEROL, DISLIPIDEMIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A.; SANTOS, Raul D.; SPOSITO, Andrei C.; et al. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013. Arquivos Brasileiros de Cardiologia, São Paulo, v. 108, n. 5, p. 411-416, 2017. Disponível em: < http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf > DOI: 10.5935/abc.20170055.
APA
Lotufo, P. A., Santos, R. D., Sposito, A. C., Bertolami, M., Rocha-Faria Neto, J., Izar, M. C., et al. (2017). Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013. Arquivos Brasileiros de Cardiologia, 108( 5), 411-416. doi:10.5935/abc.20170055
NLM
Lotufo PA, Santos RD, Sposito AC, Bertolami M, Rocha-Faria Neto J, Izar MC, Szwarcwald C, Prado RR, Stoppa SR, Malta DC, Bensenor IM. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 5): 411-416.Available from: http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf
Vancouver
Lotufo PA, Santos RD, Sposito AC, Bertolami M, Rocha-Faria Neto J, Izar MC, Szwarcwald C, Prado RR, Stoppa SR, Malta DC, Bensenor IM. Prevalência de Diagnóstico Médico de Colesterol Alto Autorreferido na População Brasileira: Análise da Pesquisa Nacional de Saúde, 2013 [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 5): 411-416.Available from: http://www.scielo.br/pdf/abc/v108n5/pt_0066-782X-abc-108-05-0411.pdf
Artigo de periodico
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) (2017)
Bertoluci, Marcello Casaccia; Moreira, Rodrigo Oliveira; Faludi, André; Izar, Maria Cristina; Schaan, Beatriz D.; Valerio, Cynthia Melissa; Bertolami, Marcelo Chiara; Chacra, Ana Paula; Malachias, Marcus Vinicius Bolivar; Vencio, Sérgio; Saraiva, José Francisco Kerr; Betti, Roberto; Turatti, Luiz; Fonseca, Francisco Antonio Helfenstein; Bianco, Henrique Tria; Sulzbach, Marta; Bertolami, Adriana; Salles, João Eduardo Nunes; Hohl, Alexandre; Trujilho, Fábio; Lima, Eduardo Gomes; Miname, Marcio Hiroshi; Zanella, Maria Teresa; Lamounier, Rodrigo; Sá, João Roberto; Amodeo, Celso; Pires, Antonio Carlos; Santos, Raul D.
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: DIABETES MELLITUS, GUIAS, DOENÇAS CARDIOVASCULARES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOLUCI, Marcello Casaccia; MOREIRA, Rodrigo Oliveira; FALUDI, André; et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, London, v. 9, n. 53, p. 36 , 2017. Disponível em: < https://doi.org/10.1186/s13098-017-0251-z > DOI: 10.1186/s13098-017-0251-z.
APA
Bertoluci, M. C., Moreira, R. O., Faludi, A., Izar, M. C., Schaan, B. D., Valerio, C. M., et al. (2017). Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, 9( 53), 36 . doi:10.1186/s13098-017-0251-z
NLM
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .Available from: https://doi.org/10.1186/s13098-017-0251-z
Vancouver
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .Available from: https://doi.org/10.1186/s13098-017-0251-z
Artigo de periodico-carta/editorial
Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] (2017)
Rocha, Viviane Z.; Santos, Raul D.
Source: Archives of Endocrinology and Metabolism. Unidade: FM
Subjects: ADULTOS, ARTERIOSCLEROSE, MULHERES, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Viviane Z.; SANTOS, Raul D. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial]. Archives of Endocrinology and Metabolism[S.l: s.n.], 2017.Disponível em: DOI: 10.1590/2359-3997000000264.
APA
Rocha, V. Z., & Santos, R. D. (2017). Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial]. Archives of Endocrinology and Metabolism. São Paulo. doi:10.1590/2359-3997000000264
NLM
Rocha VZ, Santos RD. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 2): 105-107.Available from: http://www.scielo.br/pdf/aem/v61n2/0004-2730-aem-61-2-0105.pdf
Vancouver
Rocha VZ, Santos RD. Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes [Editorial] [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 2): 105-107.Available from: http://www.scielo.br/pdf/aem/v61n2/0004-2730-aem-61-2-0105.pdf
Artigo de periodico
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab (2017)
Ridker, Paul M.; Tardif, Jean-Claude; Amarenco, Pierre; Duggan, William; Glynn, Robert J.; Jukema, J. Wouter; Kastelein, John J.P.; Kim, Albert M.; Koenig, Wolfgang; Nissen, Steven; Revkin, James; Rose, Lynda M.; Santos, Raul D.; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M.; TARDIF, Jean-Claude; AMARENCO, Pierre; et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, Boston, v. 376, n. 16, p. 1517-1526, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062 > DOI: 10.1056/NEJMoa1614062.
APA
Ridker, P. M., Tardif, J. -C., Amarenco, P., Duggan, W., Glynn, R. J., Jukema, J. W., et al. (2017). Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, 376( 16), 1517-1526. doi:10.1056/NEJMoa1614062
NLM
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Vancouver
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Artigo de periodico
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? (2016)
Banerjee, Yajnavalka; Santos, Raul D.; Al-Rasadi, Khalid; Rizzo, Manfredi
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BANERJEE, Yajnavalka; SANTOS, Raul D.; AL-RASADI, Khalid; RIZZO, Manfredi. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? Atherosclerosis, Amsterdam, v. 248, n. 1, p. 62-75, 2016. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018 > DOI: 10.1016/j.atherosclerosis.2016.02.018.
APA
Banerjee, Y., Santos, R. D., Al-Rasadi, K., & Rizzo, M. (2016). Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? Atherosclerosis, 248( 1), 62-75. doi:10.1016/j.atherosclerosis.2016.02.018
NLM
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018
Vancouver
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018
Artigo de periodico
Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia (2016)
Silva, Pãmela R. S.; Jannes, Cinthia E.; Marsiglia, Julia D. C.; Krieger, Jose E.; Santos, Raul D.; Pereira, Alexandre C.
Source: Atherosclerosis. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, SINAIS E SINTOMAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Pãmela R. S.; JANNES, Cinthia E.; MARSIGLIA, Julia D. C.; et al. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia. Atherosclerosis, Amsterdam, v. 248, n. 1, p. 144-150, 2016. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023 > DOI: 10.1016/j.atherosclerosis.2016.05.023.
APA
Silva, P. R. S., Jannes, C. E., Marsiglia, J. D. C., Krieger, J. E., Santos, R. D., & Pereira, A. C. (2016). Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia. Atherosclerosis, 248( 1), 144-150. doi:10.1016/j.atherosclerosis.2016.05.023
NLM
Silva PRS, Jannes CE, Marsiglia JDC, Krieger JE, Santos RD, Pereira AC. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia [Internet]. Atherosclerosis. 2016 ; 248( 1): 144-150.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023
Vancouver
Silva PRS, Jannes CE, Marsiglia JDC, Krieger JE, Santos RD, Pereira AC. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia [Internet]. Atherosclerosis. 2016 ; 248( 1): 144-150.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.023
Artigo de periodico
Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis (2016)
Rocha, Viviane Z.; Ras, Rouyanne T.; Gagliardi, Ana C.; Mangili, Leonardo C.; Trautwein, Elke A.; Santos, Raul D.
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, INFLAMAÇÃO, REVISÃO SISTEMÁTICA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Viviane Z.; RAS, Rouyanne T.; GAGLIARDI, Ana C.; et al. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis. Atherosclerosis, Amsterdam, v. 248, n. 1, p. 76-83, 2016. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035 > DOI: 10.1016/j.atherosclerosis.2016.01.035.
APA
Rocha, V. Z., Ras, R. T., Gagliardi, A. C., Mangili, L. C., Trautwein, E. A., & Santos, R. D. (2016). Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis. Atherosclerosis, 248( 1), 76-83. doi:10.1016/j.atherosclerosis.2016.01.035
NLM
Rocha VZ, Ras RT, Gagliardi AC, Mangili LC, Trautwein EA, Santos RD. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis [Internet]. Atherosclerosis. 2016 ; 248( 1): 76-83.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035
Vancouver
Rocha VZ, Ras RT, Gagliardi AC, Mangili LC, Trautwein EA, Santos RD. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis [Internet]. Atherosclerosis. 2016 ; 248( 1): 76-83.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.035
Artigo de periodico
Homozygous familial hypercholesterolemia: phenotype rules! (2016)
Santos, Raul D.
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, GENÓTIPOS, DOENÇAS HEREDITÁRIAS, HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. Homozygous familial hypercholesterolemia: phenotype rules!. Atherosclerosis, Amsterdam, v. 248, n. 1, p. 252-254, 2016. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009 > DOI: 10.1016/j.atherosclerosis.2016.03.009.
APA
Santos, R. D. (2016). Homozygous familial hypercholesterolemia: phenotype rules!. Atherosclerosis, 248( 1), 252-254. doi:10.1016/j.atherosclerosis.2016.03.009
NLM
Santos RD. Homozygous familial hypercholesterolemia: phenotype rules! [Internet]. Atherosclerosis. 2016 ; 248( 1): 252-254.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009
Vancouver
Santos RD. Homozygous familial hypercholesterolemia: phenotype rules! [Internet]. Atherosclerosis. 2016 ; 248( 1): 252-254.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.009
Artigo de periodico
Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia (2015)
Santos, Raul D.; Raal, Frederick J.; Donovan, Joanne M.; Crowell, William C.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, OLIGOPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D.; RAAL, Frederick J.; DONOVAN, Joanne M.; CROWELL, William C. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, New York, v. 9, n. 2, p. 201-209, 2015. Disponível em: < http://dx.doi.org/10.1016/j.jacl.2014.12.008 > DOI: 10.1016/j.jacl.2014.12.008.
APA
Santos, R. D., Raal, F. J., Donovan, J. M., & Crowell, W. C. (2015). Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia. Journal of clinical lipidology, 9( 2), 201-209. doi:10.1016/j.jacl.2014.12.008
NLM
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.Available from: http://dx.doi.org/10.1016/j.jacl.2014.12.008
Vancouver
Santos RD, Raal FJ, Donovan JM, Crowell WC. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia [Internet]. Journal of clinical lipidology. 2015 ; 9( 2): 201-209.Available from: http://dx.doi.org/10.1016/j.jacl.2014.12.008
Artigo de periodico
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) (2015)
Miller, P. Elliott; Martin, Seth S.; Toth, Peter P.; Santos, Raul D.; Blaha, Michael J.; Nasir, Khurram; Virani, Salim S.; Post, Wendy S.; Blumenthal, Roger S.; Jones, Steven R.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, LIPÍDEOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILLER, P. Elliott; MARTIN, Seth S.; TOTH, Peter P.; et al. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Journal of clinical lipidology, New York, v. 9, n. 5, p. 676-683, 2015. Disponível em: < http://dx.doi.org/10.1016/j.jacl.2015.06.015 > DOI: 10.1016/j.jacl.2015.06.015.
APA
Miller, P. E., Martin, S. S., Toth, P. P., Santos, R. D., Blaha, M. J., Nasir, K., et al. (2015). Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Journal of clinical lipidology, 9( 5), 676-683. doi:10.1016/j.jacl.2015.06.015
NLM
Miller PE, Martin SS, Toth PP, Santos RD, Blaha MJ, Nasir K, Virani SS, Post WS, Blumenthal RS, Jones SR. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) [Internet]. Journal of clinical lipidology. 2015 ; 9( 5): 676-683.Available from: http://dx.doi.org/10.1016/j.jacl.2015.06.015
Vancouver
Miller PE, Martin SS, Toth PP, Santos RD, Blaha MJ, Nasir K, Virani SS, Post WS, Blumenthal RS, Jones SR. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) [Internet]. Journal of clinical lipidology. 2015 ; 9( 5): 676-683.Available from: http://dx.doi.org/10.1016/j.jacl.2015.06.015
Artigo de periodico
Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects (2015)
Jannes, Cinthia E.; Santos, Raul D.; Silva, Pãmela R. de Souza; Turolla, Luciana; Gagliardi, Ana C. M.; Marsiglia, Julia D. C.; Chacra, Ana P.; Miname, Marcio H.; Rocha, Viviane Z.; Salgado Filho, Wilson; Krieger, Jose E.; Pereira, Alexandre C.
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, APOLIPOPROTEÍNAS, LIPÍDEOS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANNES, Cinthia E.; SANTOS, Raul D.; SILVA, Pãmela R. de Souza; et al. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects. Atherosclerosis, Amsterdam, v. 238, n. 1, p. 101-107, 2015. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2014.11.009 > DOI: 10.1016/j.atherosclerosis.2014.11.009.
APA
Jannes, C. E., Santos, R. D., Silva, P. R. de S., Turolla, L., Gagliardi, A. C. M., Marsiglia, J. D. C., et al. (2015). Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects. Atherosclerosis, 238( 1), 101-107. doi:10.1016/j.atherosclerosis.2014.11.009
NLM
Jannes CE, Santos RD, Silva PR de S, Turolla L, Gagliardi ACM, Marsiglia JDC, Chacra AP, Miname MH, Rocha VZ, Salgado Filho W, Krieger JE, Pereira AC. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects [Internet]. Atherosclerosis. 2015 ; 238( 1): 101-107.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2014.11.009
Vancouver
Jannes CE, Santos RD, Silva PR de S, Turolla L, Gagliardi ACM, Marsiglia JDC, Chacra AP, Miname MH, Rocha VZ, Salgado Filho W, Krieger JE, Pereira AC. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects [Internet]. Atherosclerosis. 2015 ; 238( 1): 101-107.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2014.11.009

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration